The stock's fall snapped a five-day winning streak.

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Edwards Lifesciences (EW – Research Report) and ...

The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the ...

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

Orange County’s medical device industry remains highly active, despite the appearance of slowing growth on the surface.

Edwards Lifesciences Corp. EW is scheduled to report first-quarter 2025 results on April 23, after the market closes. In the ...

Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and ...

Edwards Lifesciences (EW) announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary ...

Edwards Lifesciences (NYSE: EW) today announced eight-year data highlighting positive long-term outcomes with its proprietary ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received ...